PlexBio CoROCO:6572 67 Net Margin % is -27.42% as of Dec. 2025. GuruFocus rates ROCO:6572 with a GF Score™ of 67/100 and a GF Value™ of NT$9.52 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 818 Medical Devices & Instruments companies, PlexBio Co ranks worse than 75.79% on this metric.
Net margin is calculated as Net Income divided by its Revenue. PlexBio Co's Net Income for the
six
months ended in Dec. 2025 was NT$-18.9 Mil. PlexBio Co's Revenue for the
six
months ended in Dec. 2025 was NT$68.8 Mil. Therefore, PlexBio Co's net margin for the quarter that ended in Dec. 2025 was -27.42%.
The historical rank and industry rank for PlexBio Co's Net Margin % or its related term are showing as below:
ROCO:6572'
s Net Margin % Range Over the Past 10 Years
Min: -1168.48 Med: -122.26 Max: -27.79
Current: -49.15
ROCO:6572's Net Margin % is ranked worse than 75.79% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs ROCO:6572: -49.15
PlexBio Co (ROCO:6572) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
PlexBio Co Net Margin % Related Terms
PlexBio Co Net Margin % Historical Data
* Premium members only.
The historical data trend for PlexBio Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6572 vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, PlexBio Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PlexBio Co Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PlexBio Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where PlexBio Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PlexBio Co (ROCO:6572) has a Net Margin % of -27.42% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on PlexBio Co and its competitors. According to the industry distribution chart, PlexBio Co ranks #620 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 75.8%.
Is PlexBio Co's Net Margin % too high?
PlexBio Co's current Net Margin % is -27.42%. Based on the distribution chart, PlexBio Co ranks #620 out of 818 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PlexBio Co has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PlexBio Co's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PlexBio Co ranks #620 out of 818 companies for Net Margin %. This places PlexBio Co in the lower half of its industry. The industry median Net Margin % is 2.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.05, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on PlexBio Co and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PlexBio Co's current Net Margin % is -27.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PlexBio Co stock overvalued right now?
Based on GuruFocus' analysis, PlexBio Co (ROCO:6572) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$9.52, compared to a current price of NT$7.62 — trading 20% below its estimated fair value. The current Net Margin % is -27.42%. PlexBio Co's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For PlexBio Co (ROCO:6572), the current Net Margin % is -27.42% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PlexBio Co (ROCO:6572) Overvalued in 2026?
Based on GuruFocus' analysis, PlexBio Co stock appears to be undervalued.
The current stock price of NT$7.62 is trading 20% below its estimated GF Value™ of NT$9.52.
GuruFocus considers PlexBio Co to be Modestly Undervalued.
Key valuation signals for ROCO:6572:
Net Margin %: -27.42%
GF Value™: NT$9.52 vs. price of NT$7.62 (20% below fair value)
No single metric tells the full story. See the ROCO:6572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PlexBio Co Ltd is a Taiwan based company involved in designing, developing and manufacturing IVD products and instrumentations. Its products are used in companion diagnostic panel, early cancer detection screening, prenatal diagnostics and for food and safety testing.
67GF Score
Get the complete analysis for ROCO:6572
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6572 has been successfully added to your 
